{"id":"W2903866675","doi":"10.1016/j.msard.2018.10.105","title":"Long-term Reduction of Relapse Rate and Confirmed Disability progression after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Opera; Multiple sclerosis; Clinical trial; Internal medicine; Surgery; Oncology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001425054,0.0002391495,0.0004636208,0.0001201438,0.00009112834,0.00001431763,0.0000438138,0.0001956855,0.00003950598],"category_scores_gemma":[0.0000768919,0.0001838195,0.0001097203,0.0002509295,0.001002209,0.0001640744,0.00005006207,0.0001403509,0.000001371669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001036764,"about_ca_system_score_gemma":0.00004009528,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004326935,"about_ca_topic_score_gemma":0.0001256753,"domain_scores_codex":[0.9984081,0.0001116828,0.0005265183,0.0004701678,0.000218667,0.0002648543],"domain_scores_gemma":[0.9991471,0.00006821007,0.0002291908,0.0002859411,0.0001199366,0.0001496166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02104315,0.001681957,0.9246199,0.0002037625,0.0001184873,0.000002225093,0.001101459,0.00000565033,0.00457201,0.000002919786,0.000004482227,0.04664406],"study_design_scores_gemma":[0.01157996,0.006116926,0.9773918,0.002888238,0.0002127442,0.000002410702,0.000233996,0.0004413176,0.0009207049,0.00001003498,0.000008739882,0.0001931588],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974255,0.001076341,0.000008544832,0.00009553528,0.0001519461,0.001111781,0.00006103369,0.00002677081,0.00004252651],"genre_scores_gemma":[0.9983547,0.001252365,0.000166409,0.000007497787,0.00001953762,0.00005607604,0.00008140861,0.00003374285,0.00002827094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05277193,"threshold_uncertainty_score":0.7495941,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01277753586088721,"score_gpt":0.2321336456996975,"score_spread":0.2193561098388103,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}